1-20 of 26
monoclonal antibodies
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting pediatric leukemia-propagating cells with anti-CD200 antibody therapy

Paraskevi Diamanti, Charlotte V. Cox, Benjamin C. Ede, Robert A. Uger, John P. Moppett, Allison Blair
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3694–3708.
https://doi.org/10.1182/bloodadvances.2020003534
Published: 2021
Includes: Supplemental data
Journal Articles

Preclinical evaluation of immunotherapeutic regimens for fetal/neonatal alloimmune thrombocytopenia

Huiying Zhi, Maria T. Ahlen, Björn Skogen, Debra K. Newman, Peter J. Newman
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3552–3562.
https://doi.org/10.1182/bloodadvances.2021004371
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic significance of FCGR2B expression for the response of DLBCL patients to rituximab or obinutuzumab treatment

Clinical Trials & Observations
Malgorzata Nowicka, Laura K. Hilton, Margaret Ashton-Key, Chantal E. Hargreaves, Chern Lee, Russell Foxall, Matthew J. Carter, Stephen A. Beers, Kathleen N. Potter, Christopher R. Bolen, Christian Klein, Andrea Knapp, Farheen Mir, Matthew Rose-Zerilli, Cathy Burton, Wolfram Klapper, David W. Scott, Laurie H. Sehn, Umberto Vitolo, Maurizio Martelli, Marek Trneny, Christopher K. Rushton, Graham W. Slack, Pedro Farinha, Jonathan C. Strefford, Mikkel Z. Oestergaard, Ryan D. Morin, Mark S. Cragg
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2945–2957.
https://doi.org/10.1182/bloodadvances.2021004770
Published: 2021
Includes: Supplemental data
Journal Articles

Electron microscopy shows that binding of monoclonal antibody PT25-2 primes integrin αIIbβ3 for ligand binding

Dragana Nešić, Martin Bush, Aleksandar Spasic, Jihong Li, Tetsuji Kamata, Makoto Handa, Marta Filizola, Thomas Walz, Barry S. Coller
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1781–1790.
https://doi.org/10.1182/bloodadvances.2020004166
Published: 2021
Includes: Supplemental data
Journal Articles

Immunotherapy perspectives in the new era of B-cell editing

Natsuko Ueda, Marine Cahen, Yannic Danger, Jérôme Moreaux, Christophe Sirac, Michel Cogné
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1770–1779.
https://doi.org/10.1182/bloodadvances.2020003792
Published: 2021
Journal Articles

Autologous stem cell transplantation after anti-PD-1 therapy for multiply relapsed or refractory Hodgkin lymphoma

Clinical Trials & Observations
Reid W. Merryman, Robert A. Redd, Taiga Nishihori, Julio Chavez, Yago Nieto, Justin M. Darrah, Uttam Rao, Michael T. Byrne, David A. Bond, Kami J. Maddocks, Michael A. Spinner, Ranjana H. Advani, Hatcher J. Ballard, Jakub Svoboda, Anurag K. Singh, Joseph P. McGuirk, Dipenkumar Modi, Radhakrishnan Ramchandren, Jason Romancik, Jonathon B. Cohen, Matthew J. Frigault, Yi-Bin Chen, Anthony V. Serritella, Justine Kline, Stephen Ansell, Sunita Nathan, Maryam Rahimian, Robin M. Joyce, Mansi Shah, Kevin A. David, Steven Park, Anne W. Beaven, Alma Habib, Veronika Bachanova, Shazia Nakhoda, Nadia Khan, Ryan C. Lynch, Stephen D. Smith, Vincent T. Ho, Ann LaCasce, Philippe Armand, Alex F. Herrera
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1648–1659.
https://doi.org/10.1182/bloodadvances.2020003556
Published: 2021
Includes: Supplemental data
Journal Articles

Integrin VLA-4 as a PET imaging biomarker of hyper-adhesion in transgenic sickle mice

Lydia A. Perkins, Lea Nyiranshuti, Lynda Little-Ihrig, Joseph D. Latoche, Kathryn E. Day, Qin Zhu, Sina Tavakoli, Prithu Sundd, Enrico M. Novelli, Carolyn J. Anderson
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4102–4112.
https://doi.org/10.1182/bloodadvances.2020002642
Published: 2020
Includes: Supplemental data
Journal Articles

The critical role of CD4 + T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma

Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, Makiko Itami, Nobuhiko Yamauchi, Junichiro Yuda, Masato Sugano, Yuuki Ohara, Yosuke Minami, Hirohisa Nakamae, Masayuki Hino, Masahiro Takeuchi, Hiroyoshi Nishikawa
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4069–4082.
https://doi.org/10.1182/bloodadvances.2020002098
Published: 2020
Includes: Supplemental data
Journal Articles

Dominant role of αIIbβ3 in platelet interactions with cross-linked fibrin fragment D-dimer

Lorena Buitrago, Hina Zafar, Yixiao Zhang, Jihong Li, Thomas Walz, Barry S. Coller
Journal: Blood Advances
Blood Adv (2020) 4 (13): 2939–2949.
https://doi.org/10.1182/bloodadvances.2020001545
Published: 2020
Journal Articles

Transient antibody targeting of CD45RC inhibits the development of graft-versus-host disease

Laetitia Boucault, Maria-Dolores Lopez Robles, Allan Thiolat, Séverine Bézie, Michael Schmueck-Henneresse, Cécile Braudeau, Nadège Vimond, Antoine Freuchet, Elodie Autrusseau, Frédéric Charlotte, Rabah Redjoul, Florence Beckerich, Mathieu Leclerc, Eliane Piaggio, Regis Josien, Hans-Dieter Volk, Sébastien Maury, José L. Cohen, Ignacio Anegon, Carole Guillonneau
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2501–2515.
https://doi.org/10.1182/bloodadvances.2020001688
Published: 2020
Includes: Supplemental data
Journal Articles

Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes

Kimberly Lin, Lingjun Zhang, Michael Kong, Maojing Yang, Yinghua Chen, Earl Poptic, Melanie Hoffner, Jijun Xu, Connie Tam, Feng Lin
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2049–2057.
https://doi.org/10.1182/bloodadvances.2020001690
Published: 2020
Includes: Supplemental data
Journal Articles

Passively transferred IgG enhances humoral immunity to a red blood cell alloantigen in mice

David R. Gruber, Amanda L. Richards, Heather L. Howie, Ariel M. Hay, Jenna N. Lebedev, Xiaohong Wang, James C. Zimring, Krystalyn E. Hudson
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1526–1537.
https://doi.org/10.1182/bloodadvances.2019001299
Published: 2020
Includes: Supplemental data
Journal Articles

Antibodies that conformationally activate ADAMTS13 allosterically enhance metalloprotease domain function

An-Sofie Schelpe, Anastasis Petri, Elien Roose, Inge Pareyn, Hans Deckmyn, Simon F. De Meyer, James T. B. Crawley, Karen Vanhoorelbeke
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1072–1080.
https://doi.org/10.1182/bloodadvances.2019001375
Published: 2020
Includes: Supplemental data
Journal Articles

Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program

Clinical Trials & Observations
Georg Gelbenegger, Christian Schoergenhofer, Ulla Derhaschnig, Nina Buchtele, Christian Sillaber, Michael Fillitz, Thomas M. Schenk, Shirley D’Sa, Ronwyn Cartwright, James C. Gilbert, Bernd Jilma, Ulrich Jaeger
Journal: Blood Advances
Blood Adv (2020) 4 (6): 997–1005.
https://doi.org/10.1182/bloodadvances.2019001321
Published: 2020
Includes: Supplemental data
Journal Articles

PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

Matthew J. Frigault, Philippe Armand, Robert A. Redd, Erin Jeter, Reid W. Merryman, Kimberly C. Coleman, Alex F. Herrera, Parastoo Dahi, Yago Nieto, Ann S. LaCasce, David C. Fisher, Samuel Y. Ng, Oreife O. Odejide, Arnold S. Freedman, Austin I. Kim, Jennifer L. Crombie, Caron A. Jacobson, Eric D. Jacobsen, Jeffrey L. Wong, Jad Bsat, Sanjay S. Patel, Jerome Ritz, Scott J. Rodig, Margaret A. Shipp, Yi-Bin Chen, Robin M. Joyce
Journal: Blood Advances
Blood Adv (2020) 4 (1): 122–126.
https://doi.org/10.1182/bloodadvances.2019000784
Published: 2020
Includes: Supplemental data
Journal Articles

Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation

Bettina P. Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, Sai-Wen Tang, Wendy W. Pang, Tom Erkers, Neeraja Kambham, Gordon J. Freeman, Rosemarie H. Dekruyff, Everett H. Meyer
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3419–3431.
https://doi.org/10.1182/bloodadvances.2019000286
Published: 2019
Includes: Supplemental data
Journal Articles

Potentiation of complement regulator factor H protects human endothelial cells from complement attack in aHUS sera

Richard B. Pouw, Mieke C. Brouwer, Marlon de Gast, Anna E. van Beek, Lambertus P. van den Heuvel, Christoph Q. Schmidt, Arie van der Ende, Pilar Sánchez-Corral, Taco W. Kuijpers, Diana Wouters
Journal: Blood Advances
Blood Adv (2019) 3 (4): 621–632.
https://doi.org/10.1182/bloodadvances.2018025692
Published: 2019
Includes: Supplemental data
Journal Articles

HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR

Kavita Bisht, Marion E. Brunck, Taichi Matsumoto, Crystal McGirr, Bianca Nowlan, Whitney Fleming, Thomas Keech, Graham Magor, Andrew C. Perkins, Julie Davies, Gail Walkinshaw, Lee Flippin, Ingrid G. Winkler, Jean-Pierre Levesque
Journal: Blood Advances
Blood Adv (2019) 3 (3): 406–418.
https://doi.org/10.1182/bloodadvances.2018017566
Published: 2019
Includes: Supplemental data
Journal Articles

Long-term follow-up of a phase 3 clinical trial of inolimomab for the treatment of primary steroid refractory aGVHD

Clinical Trials & Observations
Gérard Socié, Noel Milpied, Ibrahim Yakoub-Agha, Jacques-Olivier Bay, Sabine Fürst, Karin Bilger, Felipe Suarez, Mauricette Michallet, Philippe Lewalle, David Liens, Catherine Mathis, Eric Guemas, Jean-Paul Vernant
Journal: Blood Advances
Blood Adv (2019) 3 (2): 184–186.
https://doi.org/10.1182/bloodadvances.2018028282
Published: 2019
Journal Articles

Inotuzumab: from preclinical development to success in B-cell acute lymphoblastic leukemia

Clinical Trials & Observations
Joseph Wynne, David Wright, Wendy Stock
Journal: Blood Advances
Blood Adv (2019) 3 (1): 96–104.
https://doi.org/10.1182/bloodadvances.2018026211
Published: 2019